BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 35684022)

  • 1. Effect of Dietary and Lifestyle Interventions on the Amelioration of NAFLD in Patients with Metabolic Syndrome: The FLIPAN Study.
    Montemayor S; Bouzas C; Mascaró CM; Casares M; Llompart I; Abete I; Angullo-Martinez E; Zulet MÁ; Martínez JA; Tur JA
    Nutrients; 2022 May; 14(11):. PubMed ID: 35684022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to Mediterranean Diet and NAFLD in Patients with Metabolic Syndrome: The FLIPAN Study.
    Montemayor S; Mascaró CM; Ugarriza L; Casares M; Llompart I; Abete I; Zulet MÁ; Martínez JA; Tur JA; Bouzas C
    Nutrients; 2022 Aug; 14(15):. PubMed ID: 35956364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between Physical Activity and Non-Alcoholic Fatty Liver Disease in Adults with Metabolic Syndrome: The FLIPAN Study.
    Mascaró CM; Bouzas C; Montemayor S; Casares M; Gómez C; Ugarriza L; Borràs PA; Martínez JA; Tur JA
    Nutrients; 2022 Mar; 14(5):. PubMed ID: 35268038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a Six-Month Lifestyle Intervention on the Physical Activity and Fitness Status of Adults with NAFLD and Metabolic Syndrome.
    Mascaró CM; Bouzas C; Montemayor S; Casares M; Llompart I; Ugarriza L; Borràs PA; Martínez JA; Tur JA
    Nutrients; 2022 Apr; 14(9):. PubMed ID: 35565780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between dietary intake and the presence of the metabolic syndrome in patients with non-alcoholic fatty liver disease.
    Georgoulis M; Kontogianni MD; Margariti A; Tiniakos D; Fragopoulou E; Zafiropoulou R; Papatheodoridis G
    J Hum Nutr Diet; 2015 Aug; 28(4):409-15. PubMed ID: 25988570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial.
    Katsagoni CN; Papatheodoridis GV; Ioannidou P; Deutsch M; Alexopoulou A; Papadopoulos N; Papageorgiou MV; Fragopoulou E; Kontogianni MD
    Br J Nutr; 2018 Jul; 120(2):164-175. PubMed ID: 29947322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of lifestyle factors and staple foods from the Mediterranean diet on non-alcoholic fatty liver disease among older individuals with metabolic syndrome features.
    Bullón-Vela V; Abete I; Tur JA; Pintó X; Corbella E; Martínez-González MA; Toledo E; Corella D; Macías M; Tinahones F; Fitó M; Estruch R; Ros E; Salas-Salvadó J; Daimiel L; Zulet MA; Martínez JA;
    Nutrition; 2020 Mar; 71():110620. PubMed ID: 31838461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Energy Expenditure Improved Risk Factors Associated with Renal Function Loss in NAFLD and MetS Patients.
    Abbate M; Mascaró CM; Montemayor S; Barbería-Latasa M; Casares M; Gómez C; Angullo-Martinez E; Tejada S; Abete I; Zulet MA; Sureda A; Martínez JA; Tur JA
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33672073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences among patients with and without nonalcoholic fatty liver disease having elevated alanine aminotransferase levels at various stages of metabolic syndrome.
    Sogabe M; Okahisa T; Kurihara T; Takehara M; Kagemoto K; Okazaki J; Kida Y; Hirao A; Tanaka H; Tomonari T; Taniguchi T; Okamoto K; Nakasono M; Takayama T
    PLoS One; 2020; 15(8):e0238388. PubMed ID: 32866186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between Non-Alcoholic Fatty Liver Disease and Mediterranean Lifestyle: A Systematic Review.
    Mascaró CM; Bouzas C; Tur JA
    Nutrients; 2021 Dec; 14(1):. PubMed ID: 35010923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease.
    Biolato M; Manca F; Marrone G; Cefalo C; Racco S; Miggiano GA; Valenza V; Gasbarrini A; Miele L; Grieco A
    World J Gastroenterol; 2019 Jan; 25(4):509-520. PubMed ID: 30700946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between Stages of Hepatic Steatosis and Physical Activity Performance in Adults with Metabolic Syndrome: A Cross-Sectional Analysis in FLIPAN Study.
    Mascaró CM; Bouzas C; Montemayor S; Casares M; Gómez C; Ugarriza L; Borràs PA; Martínez JA; Tur JA
    Nutrients; 2022 Apr; 14(9):. PubMed ID: 35565758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypocaloric high-protein diet improves clinical and biochemical markers in patients with nonalcoholic fatty liver disease (NAFLD).
    Bezerra Duarte SM; Faintuch J; Stefano JT; Sobral de Oliveira MB; de Campos Mazo DF; Rabelo F; Vanni D; Nogueira MA; Carrilho FJ; Marques Souza de Oliveira CP
    Nutr Hosp; 2014 Jan; 29(1):94-101. PubMed ID: 24483967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness and acceptability of Mediterranean diet and calorie restriction in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis.
    Haigh L; Kirk C; El Gendy K; Gallacher J; Errington L; Mathers JC; Anstee QM
    Clin Nutr; 2022 Sep; 41(9):1913-1931. PubMed ID: 35947894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the Mediterranean Diet Have Any Effect on Lipid Profile, Central Obesity and Liver Enzymes in Non-Alcoholic Fatty Liver Disease (NAFLD) Subjects? A Systematic Review and Meta-Analysis of Randomized Control Trials.
    Del Bo' C; Perna S; Allehdan S; Rafique A; Saad S; AlGhareeb F; Rondanelli M; Tayyem RF; Marino M; Martini D; Riso P
    Nutrients; 2023 May; 15(10):. PubMed ID: 37242133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome and biochemical changes among non-alcoholic fatty liver disease patients attending a tertiary care hospital of Nepal.
    Pardhe BD; Shakya S; Bhetwal A; Mathias J; Khanal PR; Pandit R; Shakya J; Joshi HO; Marahatta SB
    BMC Gastroenterol; 2018 Jul; 18(1):109. PubMed ID: 29980170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary Interventions in Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
    Houttu V; Csader S; Nieuwdorp M; Holleboom AG; Schwab U
    Front Nutr; 2021; 8():716783. PubMed ID: 34368214
    [No Abstract]   [Full Text] [Related]  

  • 19. A vegetarian diet does not protect against nonalcoholic fatty liver disease (NAFLD): A cross-sectional study between Buddhist priests and the general population.
    Choi SH; Oh DJ; Kwon KH; Lee JK; Koh MS; Lee JH; Kang HW
    Turk J Gastroenterol; 2015 Jul; 26(4):336-43. PubMed ID: 26039004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrahepatic Fat Content and COVID-19 Lockdown in Adults with NAFLD and Metabolic Syndrome.
    Montemayor S; Mascaró CM; Ugarriza L; Casares M; Gómez C; Martínez JA; Tur JA; Bouzas C
    Nutrients; 2022 Aug; 14(17):. PubMed ID: 36079720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.